Genetic test for early valve disease in bicuspid aortic valve
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how genes may affect the risk of calcium buildup in the aortic valve in people with a bicuspid aortic valve. By joining, you help researchers find better ways to predict and manage this heart condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a bicuspid aortic valve (a heart valve with two flaps instead of three), confirmed by imaging or surgery.
- You must be between 20 and 80 years old.
- Your aortic valve function should be either mild or less (normal group) or moderate to severe (calcification group) in terms of narrowing or leakage.
- You cannot have advanced kidney disease (stage 3 or higher).
- You cannot have other inherited heart conditions or a serious illness that limits life expectancy to less than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information from adults with bicuspid aortic valve disease. It may help doctors better understand outcomes and guide future care for patients and families affected by this condition.
This trial looks at how the ascending aorta (the main artery near the heart) changes over time after transcatheter aortic valve replacement. It may help doctors predict who is at risk of aorta enlargement after this less-invasive valve procedure.
This study looks for genetic (inherited) differences that may be linked to bicuspid aortic valve (BAV). It includes people with BAV and close family members to help understand why BAV happens and whether genes play a role.
This study looks at people with a bicuspid aortic valve (a valve with two flaps instead of three) in Chinese patients. It collects information about this condition to better understand it.
This study follows patients who have a bicuspid aortic valve—a heart valve with two leaflets instead of three. Researchers track how this condition changes over time to better understand its long-term effects and help guide future care.
This study looks at blood and/or body signals (called biomarkers) to understand why aortic valve narrowing may worsen and what outcomes people have. You may be able to help researchers by undergoing regular heart care plus additional testing like MRI or CT if you qualify.
Hear when a new Bicuspid Aortic Valve trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.